Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luis F de Castro

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
American Journal of Human Genetics|August 23, 2025
Single-cell analysis of human fibrous dysplasia bone reveals a fibrotic transcriptome and GNAS variants in endothelial, perivascular, and stromal cellsKelly L Wentworth, Fernando A Fierro, Tania A Moody, et al.
Bone|January 14, 2026
Gα<sub>s</sub> variant detection discerns skeletal cell types involved in fibrous dysplasia pathogenesisZachary Michel, Vivian MacDonald, Aleena Arif, et al.
Bone Research|February 20, 2024
RANKL inhibition reduces lesional cellularity and Gα<sub>s</sub> variant expression and enables osteogenic maturation in fibrous dysplasiaLuis F de Castro, Jarred M Whitlock, Zachary Michel, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|November 30, 2018
Activation of RANK/RANKL/OPG Pathway Is Involved in the Pathophysiology of Fibrous Dysplasia and Associated With Disease BurdenLuis F de Castro, Andrea B Burke, Howard D Wang, et al.
The New England Journal of Medicine|February 22, 2023
Safety and Efficacy of Denosumab for Fibrous Dysplasia of BoneLuis F de Castro, Zachary Michel, Kristen Pan, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|December 31, 2013
Biglycan modulates angiogenesis and bone formation during fracture healingAgnes D Berendsen, Emily L Pinnow, Azusa Maeda, et al.
Stem Cells (Dayton, Ohio)|December 20, 2014
p53 loss increases the osteogenic differentiation of bone marrow stromal cellsYunlong He, Luis F de Castro, Min Hwa Shin, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 12, 2022
Determination of FGF23 Levels for the Diagnosis of FGF23-Mediated HypophosphatemiaIris R Hartley, Rachel I Gafni, Kelly L Roszko, et al.
Scientific Reports|April 28, 2017
Manufacturing Differences Affect Human Bone Marrow Stromal Cell Characteristics and Function: Comparison of Production Methods and Products from Multiple CentersShutong Liu, Luis F de Castro, Ping Jin, et al.
Plos One|August 27, 2013
WISP1/CCN4: a potential target for inhibiting prostate cancer growth and spread to boneMitsuaki Ono, Colette A Inkson, Robert Sonn, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
American Journal of Human Genetics|August 23, 2025
Single-cell analysis of human fibrous dysplasia bone reveals a fibrotic transcriptome and GNAS variants in endothelial, perivascular, and stromal cellsKelly L Wentworth, Fernando A Fierro, Tania A Moody, et al.
Bone|January 14, 2026
Gα<sub>s</sub> variant detection discerns skeletal cell types involved in fibrous dysplasia pathogenesisZachary Michel, Vivian MacDonald, Aleena Arif, et al.
Bone Research|February 20, 2024
RANKL inhibition reduces lesional cellularity and Gα<sub>s</sub> variant expression and enables osteogenic maturation in fibrous dysplasiaLuis F de Castro, Jarred M Whitlock, Zachary Michel, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|November 30, 2018
Activation of RANK/RANKL/OPG Pathway Is Involved in the Pathophysiology of Fibrous Dysplasia and Associated With Disease BurdenLuis F de Castro, Andrea B Burke, Howard D Wang, et al.
The New England Journal of Medicine|February 22, 2023
Safety and Efficacy of Denosumab for Fibrous Dysplasia of BoneLuis F de Castro, Zachary Michel, Kristen Pan, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|December 31, 2013
Biglycan modulates angiogenesis and bone formation during fracture healingAgnes D Berendsen, Emily L Pinnow, Azusa Maeda, et al.
Stem Cells (Dayton, Ohio)|December 20, 2014
p53 loss increases the osteogenic differentiation of bone marrow stromal cellsYunlong He, Luis F de Castro, Min Hwa Shin, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 12, 2022
Determination of FGF23 Levels for the Diagnosis of FGF23-Mediated HypophosphatemiaIris R Hartley, Rachel I Gafni, Kelly L Roszko, et al.
Scientific Reports|April 28, 2017
Manufacturing Differences Affect Human Bone Marrow Stromal Cell Characteristics and Function: Comparison of Production Methods and Products from Multiple CentersShutong Liu, Luis F de Castro, Ping Jin, et al.
Plos One|August 27, 2013
WISP1/CCN4: a potential target for inhibiting prostate cancer growth and spread to boneMitsuaki Ono, Colette A Inkson, Robert Sonn, et al.
Pageof 3